Key participants in Interventional Oncology Devices market include Sirtex Medical Limited, Teleflex Incorporated, Boston Scientific Corporation, INterface BIOmaterials B.V., Merit Medical Systems, Inc., BTG International Limited, IMBiotechnologies Ltd., IceCure Medical Ltd, HealthTronics, Inc., and Cook Medical Inc., among others.

Vancouver, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) -- The global Interventional Oncology Devices Market is forecasted to be worth USD 3.11 Billion by 2027, according to a current analysis by Emergen Research. Over the forecasted period, the global market of Interventional Oncology Devices is anticipated to expand significantly, owing to the rising funding for cancer research by several private companies. Besides, the rising prevalence of fo cancer is expected to drive the market growing rapidly over the forecasted period. The number of deaths of men and women is projected to rise by 15.2% by 2020. Cancer accounted for 9.6 million deaths till now, according to the World Health Organization (WHO), with 70.0 % of new cases of cancer anticipated to be recorded within the next two decades. Furthermore, the rising advantageous repayment for interventional oncology treatment is anticipated to augment the market growth shortly.

However, during the forecast period, stringent regulatory changes are expected to restrain market development.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/387

Key Highlights From The Report

• Key participants include Sirtex Medical Limited, Teleflex Incorporated, Boston Scientific Corporation, INterface BIOmaterials B.V., Merit Medical Systems, Inc., BTG International Limited, IMBiotechnologies Ltd., IceCure Medical Ltd, HealthTronics, Inc., and Cook Medical Inc., among others.

• In May 2019, Boston Scientific Corporation acquired Vertiflex, Inc. The incorporation will enhance the pain management portfolio and its leadership plan for the pain category, whereas simultaneously offering doctors with effective non-opioid pain management solutions.

• During the forecast period, the ablation segment will experience significant growth. Ablation kills cancer cells with the use of electrical heat generation. The doctor uses imaging tests to guide a tiny needle through the skin into the cancer tissue.

• Over the forecasted timeframe, the Transcatheter Arterial Radioembolization is forecasted to dominate the market since this process helps better liver functioning and ensure no extrahepatic spreading.

• Due to the rising incidence of breast cancer among women at the current time, the breast cancer segment is anticipated to witness substantial growth with a CAGR of 6.7%.

• The Asia Pacific market is expected to expand at the fastest rate during the forecast timeline due to the growing proliferation of interventional oncology technology, the growing cancer incidence, and the aging population.

Check Our Prices@ https://www.emergenresearch.com/select-license/387
Emergen Research has segmented the global Interventional Oncology Devices Market on the basis of product type, process, cancer type, and region:

• Product Type Outlook (Revenue, USD Billion; 2017-2027)

  • Support

  • Embolization

  • Ablation

• Process Outlook (Revenue, USD Billion; 2017-2027)

  • Non-Thermal Tumor Ablation

  • Thermal Tumor Ablation

  • Transcatheter Arterial Radioembolization

  • Transcatheter Arterial Chemoembolization

  • Bland Embolization or Transcatheter Arterial Embolization

• Cancer Type Outlook (Revenue, USD Billion; 2017-2027)

  • Lung Cancer

  • Liver Cancer

  • Bone Cancer

  • Breast Cancer

  • Prostate Cancer

  • Kidney Cancer

  • Others

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/interventional-oncology-devices-market

• Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America

    1. U.S.

    2. Canada

    3. Mexico

  • Europe

    1. Germany

    2. UK

    3. France

    4. BENELUX

    5. Rest of Europe

  • Asia Pacific

    1. China

    2. Japan

    3. South Korea

    4. India

    5. Rest of APAC

  • Latin America

    1. Brazil

    2. Rest of LATAM

  • MEA

    1. Saudi Arabia

    2. UAE

    3. Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-interventional-oncology-devices-market